These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23665456)

  • 21. Protein biomarker discovery for head and neck cancer.
    Schaaij-Visser TB; Brakenhoff RH; Leemans CR; Heck AJ; Slijper M
    J Proteomics; 2010 Sep; 73(10):1790-803. PubMed ID: 20139037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
    Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential biomarkers of head and neck squamous cell carcinoma using iTRAQ based quantitative proteomic approach.
    Babu N; Mohan S; Nanjappa V; Chavan S; Advani J; Khan AA; Renuse S; Radhakrishnan A; Prasad TSK; Kumar RV; Ray JG; Biswas M; Thiyagarajan S; Califano JA; Sidransky D; Gowda H; Chatterjee A
    Data Brief; 2018 Aug; 19():1124-1130. PubMed ID: 30225281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
    Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
    Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
    Tripathi SC; Matta A; Kaur J; Grigull J; Chauhan SS; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Siu KW
    PLoS One; 2010 Aug; 5(8):e11939. PubMed ID: 20689826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.
    Melle C; Ernst G; Schimmel B; Bleul A; Koscielny S; Wiesner A; Bogumil R; Moller U; Osterloh D; Halbhuber KJ; von Eggeling F
    Mol Cell Proteomics; 2003 Jul; 2(7):443-52. PubMed ID: 12824440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.
    Yamashita T; Shimada H; Tanaka S; Araki K; Tomifuji M; Mizokami D; Tanaka N; Kamide D; Miyagawa Y; Suzuki H; Tanaka Y; Shiotani A
    Cancer Med; 2016 Mar; 5(3):415-25. PubMed ID: 26798989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
    Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
    Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteome-wide analysis of head and neck squamous cell carcinomas using laser-capture microdissection and tandem mass spectrometry.
    Baker H; Patel V; Molinolo AA; Shillitoe EJ; Ensley JF; Yoo GH; Meneses-García A; Myers JN; El-Naggar AK; Gutkind JS; Hancock WS
    Oral Oncol; 2005 Feb; 41(2):183-99. PubMed ID: 15695121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasis.
    Bohnenberger H; Kaderali L; Ströbel P; Yepes D; Plessmann U; Dharia NV; Yao S; Heydt C; Merkelbach-Bruse S; Emmert A; Hoffmann J; Bodemeyer J; Reuter-Jessen K; Lois AM; Dröge LH; Baumeister P; Walz C; Biggemann L; Walter R; Häupl B; Comoglio F; Pan KT; Scheich S; Lenz C; Küffer S; Bremmer F; Kitz J; Sitte M; Beißbarth T; Hinterthaner M; Sebastian M; Lotz J; Schildhaus HU; Wolff H; Danner BC; Brandts C; Büttner R; Canis M; Stegmaier K; Serve H; Urlaub H; Oellerich T
    EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30097507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma.
    Wang L; Jiang H; Li W; Jia C; Zhang H; Sun Y; Chen X; Song X
    Arch Oral Biol; 2017 Jan; 73():105-112. PubMed ID: 27744260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
    Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TS; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
    Sci Rep; 2016 Oct; 6():36132. PubMed ID: 27796319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Growth Response 1-Dependent Downregulation of Matrix Metalloproteinase 9 and Mouse Double Minute 2 Attenuates Head and Neck Squamous Cell Carcinoma Metastasis.
    Kim J; Kang SM; Oh SY; Kang SH; Lee I; Hwang JC; Lee HJ; Choi SY; Hong SH
    Cell Physiol Biochem; 2018; 50(5):1869-1881. PubMed ID: 30396177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.
    Ganguli-Indra G; Wasylyk C; Liang X; Millon R; Leid M; Wasylyk B; Abecassis J; Indra AK
    PLoS One; 2009; 4(4):e5367. PubMed ID: 19399189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers.
    Ralhan R; Masui O; Desouza LV; Matta A; Macha M; Siu KW
    Proteomics; 2011 Jun; 11(12):2363-76. PubMed ID: 21598386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma.
    Han L; Tang MM; Xu X; Jiang B; Huang J; Feng X; Qiang J
    Oncotarget; 2016 Jul; 7(29):45052-45059. PubMed ID: 27281608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.
    Geomela PA; Kontos CK; Yiotakis I; Fragoulis EG; Scorilas A
    BMC Cancer; 2012 Oct; 12():484. PubMed ID: 23083099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.